Atlas Trials

A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients

Clinical trial NCT03863860 · COMPLETED

Trial details

NCT number
NCT03863860
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2019-04-30
Primary completion
2022-01-10
Enrollment
252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.